Pruvonertinib
Treatment Side Effects
Suzhou Puhe Pharmaceutical Technology Co., LTDSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
13 Active assets in the Treatment Side Effects cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Velpatasvir Alexandria University | Phase 4 | BB |
AUTOLOGOUS CONDITIONED PLASMA Star Spine and Sport | Phase 4 | BB |
Sofosbuvir Alexandria University | Phase 4 | BB |
NEPENTHE Tiva Group | Phase 4 | BB |
NADROPARIN Rijnstate Hospital | Phase 4 | BB |
View all 37 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →